| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745113 | Parkinsonism & Related Disorders | 2015 | 6 Pages |
Abstract
STN-DBS allows for a reduction in the dosage of medication and the costs are similarly reduced. In this cohort different medication groups were reduced to a similar extent. Patients' demographic factors did not play a major role in the selection of treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Athanasia Alexoudi, Ali Shalash, Karina Knudsen, Karsten Witt, Maximilian Mehdorn, Jens Volkmann, Günther Deuschl,